Life Science Company News

Recording of the Third Quarter 2019 Investor Conference Webinar

On December 11 JSC Olainfarm organized its Investor Conference Online Webinar. During the webinar the Chairman of Management Board Jeroen Weites and Investor Relations Advisor Janis Dubrovskis analyzed the financial results of third quarter and 9 months 2019 and informed about other recent activities within the company.

The recorded webinar is available online: https://bit.ly/2sg4rPa, and the presentation, demonstrated during the webinar, is available in the attachment. Methodology for alternative performance indicators is disclosed in Annual report for 2018 (page 20) and in Financial statements for 6 months period ended 30 June 2019 (page 17).

Olainfarm thanks all participants, who joined the webinar, and encourages everybody to follow company’s announcements to get information on the next webinar!

JSC Olainfarm is one of the largest companies in the Baltic States with more than 45 years of experience in production of pharmaceuticals and chemical and pharmaceutical products. The basic principle of the company is to produce reliable and effective top quality products for Latvia and the whole world. Currently, JSC Olainfarm products are exported to more than 60 countries worldwide, including the Baltic States, Russia, other CIS countries, Europe, North America, Asia and Australia.

Additional information:   
J?nis Dubrovskis
Investor Relations Advisor of JSC Olainfarm
Phone: +371 29178878
Email: janis.dubrovskis@olainfarm.com

Attachment

By: GlobeNewswire - 11 Dec 2019
Back to overview

Enhance your business development with Biotechgate